These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19623058)

  • 1. Lipoprotein(a): a causal independent risk factor for coronary heart disease?
    Gudnason V
    Curr Opin Cardiol; 2009 Sep; 24(5):490-5. PubMed ID: 19623058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a): resurrected by genetics.
    Kronenberg F; Utermann G
    J Intern Med; 2013 Jan; 273(1):6-30. PubMed ID: 22998429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a): more interesting than ever after 50 years.
    Dubé JB; Boffa MB; Hegele RA; Koschinsky ML
    Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1996 Jan; 77A():54-61. PubMed ID: 8729591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein(a) in heterozygote familial hypercholesterolemia].
    Ochoa Sosa CA; Zamora González J; González Hermosillo JA; Ize Lema I; Cardoso Saldaña G; Posadas Romero C
    Arch Inst Cardiol Mex; 1994; 64(6):549-55. PubMed ID: 7726691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
    Hung MY; Tsimikas S
    Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis in Indians and lipoprotein (a).
    Misra A
    J Assoc Physicians India; 1999 Mar; 47(3):313-7. PubMed ID: 10999128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
    Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
    Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein Lp(a) excess and coronary heart disease.
    Stein JH; Rosenson RS
    Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of lipoprotein(a) and ischemic heart disease].
    Kalina A
    Orv Hetil; 2002 Nov; 143(47):2625-9. PubMed ID: 12532648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated lipoprotein (a) blood levels as the single treatable atherosclerotic risk factor in patients with coronary artery disease.
    Bays H; Dujovne CA; Mays JB
    J Ky Med Assoc; 1993 Nov; 91(11):498-500. PubMed ID: 8270845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) and coronary heart disease in Indian population.
    Singh S; Dwivedi S; Melkani GC; Rani C; Gaur SP; Mandal SK; Mahua J
    J Assoc Physicians India; 1999 Dec; 47(12):1157-60. PubMed ID: 11225215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited dyslipidaemic disorders contributing to coronary heart disease.
    Attaullah S; Bangash R; Amanullah ; Ahmed Z; Rehman J
    J Ayub Med Coll Abbottabad; 2008; 20(4):90-3. PubMed ID: 19999214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) levels and heart transplantation atherosclerosis.
    Chang G; DeNofrio D; Desai S; Kelley MP; Rader DJ; Acker MA; Loh E
    Am Heart J; 1998 Aug; 136(2):329-34. PubMed ID: 9704698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
    Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
    BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.